Skip to main content
    B

    Bio-Rad Laboratories Inc (BIO)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $364.95
    +2.52 (+0.70%)

    Market Cap: $9.70B

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    69%(27/39)
    Avg Surprise
    +13.22%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$2.23
    Range$2.16 - $2.29
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$2.31-3.7%
    60d ago$2.31-3.7%
    30d ago$2.23-0.3%
    7d ago$2.23-0.3%
    Current$2.23
    Revenue Consensus
    $650M
    Range$648M - $652M
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$3.49
    Range$2.89 - $4.14
    3 analysts
    Revenue Consensus
    $707M
    Range$669M - $732M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$3.49---
    Sep 26EST
    		-$2.23---
    Jun 26
    Reported Aug 4
    		$2.62$2.34+11.97%Beat+0.4%
    Mar 26
    Reported Apr 30
    		$1.89$1.99-5.03%Miss-25.6%
    Dec 25
    Reported Feb 12
    		$2.51$2.70-7.04%Miss-13.4%
    Sep 25
    Reported Oct 29
    		$2.26$1.93+17.10%Beat+12.4%
    Jun 25
    Reported Jul 31
    		$2.61$1.75+49.14%Beat-16.1%
    Mar 25
    Reported May 1
    		$2.54$1.78+42.70%Beat+10.9%
    Dec 24
    Reported Feb 13
    		$2.90$2.88+0.69%Beat-6.5%
    Sep 24
    Reported Oct 30
    		$2.01$1.18+70.34%Beat-13.7%
    Jun 24
    Reported Aug 1
    		$3.11$2.02+53.96%Beat+3.7%
    Mar 24
    Reported May 7
    		$2.29$2.14+7.01%Beat-31.4%
    Dec 23
    Reported Feb 15
    		$3.10$2.87+8.01%Beat-6.3%
    Sep 23
    Reported Oct 26
    		$2.33$2.81-17.08%Miss-10.4%
    Jun 23
    Reported Aug 3
    		$3.00$2.68+11.94%Beat-11.2%
    Mar 23
    Reported May 4
    		$3.34$3.48-4.02%Miss-32.4%
    Dec 22
    Reported Feb 16
    		$3.31$3.44-3.78%Miss+3.1%
    Sep 22
    Reported Oct 27
    		$2.60$2.77-6.14%Miss-29.9%
    Jun 22
    Reported Jul 28
    		$3.38$2.77+22.02%Beat-4.5%
    Mar 22
    Reported Apr 28
    		$4.94$3.23+52.94%Beat-5.2%
    Dec 21
    Reported Feb 10
    		$3.21$2.87+11.85%Beat-20.0%
    Sep 21
    Reported Oct 28
    		$3.71$2.48+49.60%Beat+23.7%
    Jun 21
    Reported Jul 29
    		$3.54$2.70+31.11%Beat+119.9%
    Mar 21
    Reported Apr 29
    		$5.21$2.94+77.21%Beat+172.8%
    Dec 20
    Reported Feb 11
    		$4.01$3.32+20.78%Beat+72.8%
    Sep 20
    Reported Oct 29
    		$3.00$1.82+64.84%Beat+86.3%
    Jun 20
    Reported Jul 30
    		$1.61$1.15+40.00%Beat+2.5%
    Mar 20
    Reported May 6
    		$1.91$1.57+21.66%Beat+15.8%
    Dec 19
    Reported Feb 13
    		$2.32$2.45-5.31%Miss+8.9%
    Sep 19
    Reported Oct 31
    		$1.61$1.41+14.18%Beat+76.9%
    Jun 19
    Reported Aug 1
    		$1.57$1.34+17.16%Beat-4.3%
    Mar 19
    Reported May 8
    		$1.65$1.09+51.38%Beat+65.0%
    Dec 18
    Reported Feb 28
    		$2.13$1.70+25.29%Beat+317.6%
    Sep 18
    Reported Nov 1
    		$0.91$1.14-20.18%Miss+0.0%
    Jun 18
    Reported Aug 7
    		$1.64$1.28+28.13%Beat+864.7%
    Mar 18
    Reported May 8
    		$1.00$1.22-18.03%Miss+143.9%
    Dec 17
    Reported Feb 27
    		$0.51N/A-59.52%Miss+172.9%
    Sep 17
    Reported Nov 2
    		$0.91$0.60+51.67%Beat-
    Jun 17
    Reported Aug 3
    		$0.17N/A-75.00%Miss-
    Mar 17
    Reported May 4
    		$0.41$0.27+51.85%Beat-
    Dec 16
    Reported Feb 23
    		$-0.70$1.03-167.96%Miss-

    Key Metrics

    Valuation
    P/E Ratio39.33EV/EBITDAN/A
    Price/FCF24.87xFCF Yield4.02%
    Profitability
    Profit Margin8.59%Operating Margin11.20%
    ROE3.11%ROIC-3.89%
    Financial Health
    Debt/Equity0.17xInterest Coverage2.94x
    Current Ratio3.14xQuick Ratio2.33x
    Trading Statistics
    Beta1.07Avg Volume251.72K
    52-Week High$396.2352-Week Low$236.73

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$366.78
    SMA 20$371.95
    SMA 50$372.48
    SMA 200$310.62
    EMA 10$366.51
    EMA 20$369.40
    EMA 50$363.04
    EMA 200$322.59

    MACD

    Line: -2.28Signal: -0.69Hist: -1.59

    ADX

    ADX: 21.8+DI: 15.1-DI: 17.9

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down60.0
    PSAR$386.54

    Bollinger Bands

    Upper Band$389.11
    Lower Band$354.79
    %B Position923%(Upper)
    Band Width0.30

    RSI (14-Day)

    Neutral
    46.4

    Momentum Oscillators

    Stoch %K28.3
    Stoch %D29.2
    Williams %R-68.3
    ROC (10d)2.6%
    Momentum9.38
    CCI (20d)-76.5
    MFI (14d)42.1

    Volatility Measures

    ATR (14d)$11.73(3.2%)
    StdDev (20d)8.58
    Hist Vol33.5%(Moderate)

    Volume Flow

    VWAP$364.48
    OBV561.3K
    AD Line7.2M
    CMF (20d)-0.013

    Volume Metrics

    Avg Vol (20d)253.5K
    Vol Ratio1.0x
    VWMA (20d)$372.84

    Pivot Points

    R3$378.38
    R2$374.73
    R1$368.58
    Pivot Point$364.92
    S1$358.77
    S2$355.12
    S3$348.97

    Advanced Oscillators

    TSI-6.10
    Ultimate Osc42.7
    KST-23.50

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$651.00M$592.10M$693.20M$653.00M$651.60M$585.40M$667.50M$649.70M$638.50M$610.80M$681.12M$632.12M
    Cost of Revenue$305.20M$282.70M$348.00M$309.60M$306.30M$279.40M$325.50M$293.80M$283.40M$284.90M$314.81M$296.44M
    Gross Profit$345.80M$309.40M$345.20M$343.40M$345.30M$306.00M$342.00M$355.90M$355.10M$325.90M$366.32M$335.68M
    Operating Expenses$273.20M$275.30M$464.10M$278.10M$268.20M$282.30M$283.60M$291.40M$253.60M$281.30M$271.00M$244.73M
    R&D$61.20M$62.90M$70.30M$71.30M$60.50M$73.50M$79.60M$91.00M$58.90M$66.40M$63.87M$43.53M
    SG&A$212.00M$212.40M$221.00M$206.80M$207.70M$208.80M$204.00M$200.40M$194.70M$214.90M$207.12M$201.20M
    Operating Income$72.60M$34.10M$-118,900,000$65.30M$77.10M$23.70M$58.40M$64.50M$101.50M$44.60M$95.32M$90.95M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$12.10M$12.30M$12.10M$12.30M$12.60M$12.00M$12.20M$12.10M$12.30M$12.30M$12.32M$12.40M
    Income Before Tax$542.10M$-689,800,000$929.20M$-431,100,000$414.00M$83.40M$-908,900,000$861.60M$-2,786,300,000$491.10M$428.40M$137.10M
    Income Tax Expense$170.70M$-162,700,000$209.20M$-89,200,000$96.20M$19.40M$-193,100,000$208.40M$-620,800,000$107.20M$78.66M$30.84M
    Net Income$371.40M$-527,100,000$720.00M$-341,900,000$317.80M$64.00M$-715,800,000$653.20M$-2,165,500,000$383.90M$349.73M$106.26M
    EBITDA$554.20M$-677,500,000$40.90M$-418,800,000$426.60M$95.40M$1.76B$873.70M$-2,774,000,000$503.40M$1.69B$149.50M
    EBIT$554.20M$-677,500,000$40.90M$-418,800,000$426.60M$95.40M$1.76B$873.70M$-2,774,000,000$503.40M$1.69B$149.50M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BIO

    News

    Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026

    Bio-Rad Laboratories, Inc. announced it will release its third-quarter 2026 financial results on Wednesday, November 4, 2026...

    Investing News Network•10/14/26•Neutral

    Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum

    Bio-Rad Laboratories, Inc. announced that its CFO, Roop K. Lakkaraju, will participate in a fireside chat at the Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum on September 24...

    Investing News Network•9/16/26•Somewhat-Bullish

    Bio-Rad to Participate in Fireside Chat During Wells Fargo's 21st Annual Healthcare Conference

    Bio-Rad Laboratories, Inc. announced that its CFO, Roop K. Lakkaraju, will participate in a fireside chat at Wells Fargo's 21st Annual Healthcare Conference on September 9...

    Investing News Network•8/31/26•Neutral

    Bio-Rad Laboratories stock hits 52-week high at 394.22 USD

    Bio-Rad Laboratories Inc. (BIO) stock recently hit a 52-week high of $394.22, demonstrating strong market performance with significant year-to-date and 1-year gains. Despite surpassing second-quarter earnings and revenue...

    Investing.com Canada•8/27/26•Bullish

    Why Bio-Rad Laboratories (BIO) Is Up 6.7% After Restructuring Move Amid Mixed Segment Trends

    Bio-Rad Laboratories' stock is up 6.7% following a restructuring announcement aimed at cost savings and improving operating margins by 2027. This move comes as the company experiences continued growth in its digital PCR...

    Sahm•8/23/26•Neutral

    BIO Valuation and Fair Value

    P/E
    39.3x
    Forward P/E
    41.3x
    P/FCF
    24.9x
    PEG
    1.2x
    P/B
    1.4x
    See GNG's fair value

    BIO Profitability: Margins, ROIC and FCF

    Gross margin
    51.9%
    Operating margin
    11.2%
    Net margin
    8.6%
    ROIC
    -3.9%
    ROE
    3.1%
    FCF margin
    15.2%
    FCF yield
    4.0%

    BIO Competitors

    CompanyTicker
    Nuvalent IncNUVL
    Krystal Biotech IncKRYS
    Bio-Rad Laboratories IncBIO-B
    Henry Schein IncHSIC
    Twist Bioscience CorpTWST
    10X Genomics IncTXG
    The Ensign Group IncENSG
    Qiagen NVQGEN

    Sector: Healthcare

    BIO Analyst Ratings

    Consensus
    Hold
    Analysts
    5
    Strong Buy
    1
    Buy
    0
    Hold
    3
    Sell
    0
    Strong Sell
    1

    BIO Bull Case vs Bear Case

    Bull case

    • BIO converts 15.2% of revenue into free cash flow.
    • BIO beat EPS estimates in 75.0% of its last 8 reported quarters.

    Bear case

    • BIO's quarterly revenue changed -0.1% year over year.

    BIO Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    22.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $2.23
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 3 down

    Frequently Asked Questions About BIO

    Does BIO pay dividends?

    Bio-Rad Laboratories Inc (BIO) does not currently pay a regular dividend.

    What is BIO's P/E ratio?

    Bio-Rad Laboratories Inc has a price-to-earnings (P/E) ratio of 39.33.

    What is BIO's market cap?

    Bio-Rad Laboratories Inc (BIO) has a market capitalization of $9.70B with a current stock price of $364.95.

    Related stocks

    Sector: Healthcare

    All stocks starting with B

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In